Although recent studies provide evidence for a common genetic basis between complex traits 2 and Mendelian disorders, a thorough quantification of their overlap in a phenotype-specific 3 manner remains elusive. Here, we quantify the overlap of genes identified through large-scale 4 genome-wide association studies (GWAS) for 62 complex traits and diseases with genes known 5 to cause 20 broad categories of Mendelian disorders. We identify a significant enrichment of 6 phenotypically-matched Mendelian disorder genes in GWAS gene sets. Further, we observe 7 elevated GWAS effect sizes near phenotypically-matched Mendelian disorder genes. Finally, we 8 report examples of GWAS variants localized at the transcription start site or physically 9 interacting with the promoters of phenotypically-matched Mendelian disorder genes. Our results 1 0 are consistent with the hypothesis that genes that are disrupted in Mendelian disorders are 1 1 dysregulated by noncoding variants in complex traits, and demonstrate how leveraging findings 1 2 from related Mendelian disorders and functional genomic datasets can prioritize genes that are 1 3 putatively dysregulated by local and distal non-coding GWAS variants.
INTRODUCTION 1 5
Genetic architectures of human traits have traditionally been classified into two major 1 6 categories. Typically, complex traits demonstrate polygenic architectures arising from many low-1 7 effect common variants, whereas rare traits tend to have high-effect monogenic determinants 1 .
8
The underlying and practical distinction between these classes has historically been based on To identify Mendelian disorder genes, we downloaded the Online Mendelian Inheritance in Man 1 0 2 (OMIM) catalogue database 28 and identified all genes linked to Mendelian disorders satisfying 1 0 3 the following criteria: (1) disorder is Mendelian and fully penetrant, therefore excluding 1 0 4 susceptibility phenotypes and (2) molecular basis of the Mendelian disorder is known (i.e., 1 0 5 phenotype mapping key = 3). We defined loss-of-function (LOF) intolerant genes as any gene 1 0 6 with greater than 90% probability of being loss-of-function intolerant, according to the pLI score 1 0 7 (pLI > 0.9) from the Exome Aggregation Consortium (ExAC) 32 ; this score is derived from the 1 0 8 number of observed versus expected LOF variants in a given gene across approximately 1 0 9 60,000 healthy exomes. Following the same restriction and gene symbol standardization criteria 1 1 0 described above resulted in a final set of 3,446 Mendelian disorder genes and 2,978 LOF-1 1 1 intolerant genes. To identify subsets of Mendelian disorder genes linked to particular phenotypes, for each 1 1 5 complex trait we curated a set of standardized clinical phenotype terms to describe the full 1 1 6 range of relevant Mendelian phenotypes. We used these terms to search the OMIM database via API for all Mendelian disorders demonstrating these phenotypes, then extracted the gene(s) Mendelian disorder gene sets remained with an average of 375 genes per set; we include a 1 3 2 description of each cluster in Table S2 . SNP rather than only the index GWAS SNPs at each genomic risk region. ( Table S5 ), suggesting that the observed signal is not driven by any of these confounders. Of 2 7 7 note, we did observe a respective increase in average gene length between all protein-coding 2 7 8 genes, all Mendelian disorder genes, and LOF-intolerant genes (Table S5) . Therefore, it is 2 7 9
possible that our findings of enriched GWAS signal in these gene categories is due instead to 2 8 0 longer genes being more likely to tag causal variation. However, in general we did not observe a 2 8 1 significant increase in average gene length for the phenotype-specific Mendelian disorder gene 2 8 2 sets as compared to all Mendelian disorder genes (Table S5) , but still found an increase in 2 8 3 enrichment of GWAS signal (Figure 3 ), suggesting that gene length is not significantly where at least one such SNP was found; Tables S7 and S8), and identified 25 promising candidate SNPs (attaining genome-wide significance in GWAS) at TSSs that could be 3 0 0
regulating the proximal Mendelian disorder gene ( Deficiencies, MIM# 278000) causing hypercholesterolemia and hypertriglyceridemia as part of containing by regulatory epigenetic marks. Syndrome 1 (MIM# 180849) in which obesity is one of the syndromic features 28 (Figure 4C ).
2 4
These interactions can also identify the relevant isoforms of genes in disease. We identified a 3 2 5 cluster of SNPs from the credible set of variants associated with BMI that physically interact with 3 2 6 the promoter of a specific isoform of CYP19A1, a gene known to cause Aromatase Excess represent the gene, our data suggests that the shorter isoform is likely to be more relevant in In this work we used GWAS summary statistics from 62 complex traits and genes linked 3 3 9
to specific phenotypes within 20 Mendelian broad disorders to quantify the shared genetic basis 3 4 0 of complex traits and Mendelian disorders. We identified a specific enrichment of traits and Mendelian disorders.
First, our finding of a specific enrichment of phenotypically-matched and related 3 5 1
Mendelian disorder genes in GWAS regions for complex traits suggests that, across complex important role of gene regulation by non-coding variants in complex traits. However, we note 3 5 6 that our findings are limited by the power of each GWAS to detect significant associations. As GWAS become better-powered, we anticipate being able to identify phenotype-specific 3 5 8 enrichments of Mendelian disorder genes in GWAS regions for more complex traits.
3 5 9
Second, the subset of complex trait-Mendelian disorder pairs with no known shared
biology that still demonstrated significant enrichment of Mendelian disorder genes in GWAS together suggest that many complex traits and Mendelian disorders may also be linked by the 3 6 5 pleiotropic properties of the underlying genes, in addition to regulatory differences. These observations are also consistent with a multigenic or oligogenic architecture of human disease; phenotypes can provide novel insights into gene function in addition to putative drug targets. Mendelian disorders and complex traits through their effects on the same biological genes and 3 9 8 pathways, we can systematically and rationally target existing drugs for complex traits and Last, we note that our approach of examining traits and disorders at the component- previously considered to be due to environment 13 , uncovered variable penetrance for genetic 4 0 7
mutations previously thought to be sufficient to cause disease, and has suggested that genetic Beats. J Am Coll Cardiol 71, 289-291. Ototoxicity. Clin Cancer Res 23, 3325-3333. 28. Online Mendelian Inheritance in Man, OMIM (TM). Johns Hopkins University, Baltimore, from GWAS. Nat Commun 9, 1512. 35. Mancuso, N., Shi, H., Goddard, P., Kichaev, G., Gusev, A., and Pasaniuc, B. (2017) . 48. Sekar, A., Bialas, A.R., de Rivera, H., Davis, A., Hammond, T.R., Kamitaki, N., Tooley, K., each complex trait (e.g., height), we first identified matched Mendelian phenotypes (e.g., 7 8 7 undergrowth, short stature; Table S9 ). Using publicly available GWAS data, we defined the 7 8 8 "GWAS genes" for a given complex trait to be the closest upstream and closest downstream 7 8 9
protein-coding gene for every genome-wide significant variant in the GWAS. We selected 7 9 0 phenotype-matched Mendelian disorder genes by first identifying Mendelian disorders 7 9 1 expressing any of the matched Mendelian phenotypes, and then identifying all genes causing 7 9 2 any of those disorders. Mendelian disorders (blue) and pairs with unrelated phenotypes (grey) are shown. The increase in average SNP effect size per gene across four gene categories. We averaged Mendelian disorder genes, all LOF-intolerant genes, and all phenotypically-relevant Mendelian disorder genes for each trait). We normalized these averages to the average SNP effect per physically interacts with the promoter of a distant gene CREBBP. 
